Qianhai Health (00911) announced that the group anticipates reporting a net profit attributable to shareholders ranging between HK$5 million and HK$6 million for the fiscal year ending December 31, 2025. This compares to a net profit attributable to shareholders of approximately HK$1.3 million for the previous fiscal year ended December 31, 2024. The improvement in the company's consolidated net profit is primarily attributed to the absence of provisions for loss contracts during the current financial year.